NCT03982992 Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab Status WITHDRAWN Phase PHASE2
NCT03974360 Efficacy and Tolerability of Erenumab in the Prophylactic Treatment of Persistent Post-Traumatic Headache Status COMPLETED Phase PHASE2
NCT03971071 A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache Status COMPLETED Phase PHASE4
NCT03969329 A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis Status RECRUITING Phase PHASE3
NCT03951220 The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone Loss Status COMPLETED Phase N/A
NCT03944577 Impact of Evolocumab in Cardiac Transplant Patients With CAV Status COMPLETED Phase PHASE2
NCT03937154 Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03934684 Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma Status COMPLETED Phase PHASE4
NCT03931642 BLINAtumomab After R-CHOP Debulking Therapy for Patients With Richter Transformation Status COMPLETED Phase PHASE2
NCT03930186 A Phase 3B, Open-label, Single-arm Study of the Efficacy and Safety of Apremilast, in Subjects With Plaque Psoriasis That is Not Adequately Controlled by Topical Therapy Status COMPLETED Phase PHASE3
NCT03927157 Study to Evaluate Tezepelumab in Adults With Severe Uncontrolled Asthma Status COMPLETED Phase PHASE3
NCT03927144 Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients Status COMPLETED Phase PHASE4
NCT03925532 Denosumab in Treating Patients With Bone Loss Due to Donor Stem Cell Transplant Status COMPLETED Phase PHASE2
NCT03912337 Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine Status TERMINATED Phase PHASE4
NCT03904069 Study Evaluating the Safety, Tolerability, and Efficacy of FLT3 CAR-T AMG 553 in FLT3-positive Relapsed/Refractory AML Status WITHDRAWN Phase PHASE1
NCT03872401 Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke Status COMPLETED Phase PHASE3
NCT03861533 GOAL International QuERI - Protocol CHRC 2019 GOAL INTERNATIONAL Status COMPLETED Phase N/A
NCT03859427 A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma Status COMPLETED Phase PHASE3